African ancestry allelic variation at the MYH9 gene contributes to increased susceptibility to non-diabetic end-stage kidney disease in Hispanic Americans
Doron M. Behar(Rambam Health Care Campus), Karl Skorecki(Bar-Ilan University), Cheryl A. Winkler(Frederick National Laboratory for Cancer Research), Sivan Bercovici(Fresenius Medical Care (United States)), Saharon Rosset(Tel Aviv University), Shay Tzur(Hebrew University of Jerusalem), Sara Selig(Technion – Israel Institute of Technology), Walter G. Wasser(Cabrini Medical Center), George W. Nelson(Division of Undergraduate Education), Jeffrey B. Kopp(National Institute of Diabetes and Digestive and Kidney Diseases), Guennady Yudkovsky(Technion – Israel Institute of Technology)
Cited by 91
Related Papers
Genetic Restriction of HIV-1 Infection and Progression to AIDS by a Deletion Allele of the <i>CKR5</i> Structural Gene
|Science|1996|2.5k
Analytical and clinical validation of a microbial cell-free DNA sequencing test for infectious disease
|Nature Microbiology|2019|1k
Insulin Production by Human Embryonic Stem Cells
|Diabetes|2001|907
APOL1 Genetic Variants in Focal Segmental Glomerulosclerosis and HIV-Associated Nephropathy
|Journal of the American Society of Nephrology|2011|856
MYH9 is a major-effect risk gene for focal segmental glomerulosclerosis
|Nature Genetics|2008|706